
Crizotinib 250 Mg Capsules By Cvs Biotech Pvt. Ltd.
Price: 100000 INR / Box
Get Latest Price
Minimum Order Quantity :
1 Box
In Stock
Product Specifications
| Brand Name | Crizotinib 250 Mg Capsules |
| Life Span | 2 Years |
| Dosage Form | Capsules |
| Origin of Medicine | india |
| Packaging Type | box |
| Drug Type | General Medicines |
| Ingredients | Crizotinib 250 Mg Capsules |
| Physical Form | Tablets |
| Recommended For | all |
| Dosage | Capsules |
| Dosage Guidelines | yes |
| Suitable For | Women, Children, Aged Person, Teenagers, Adults, Suitable For All |
| Quantity | 1 Unit |
| Payment Terms | Cash in Advance (CID) |
| Supply Ability | 5 Per Week |
| Delivery Time | 1 Week |
| Sample Policy | Contact us for information regarding our sample policy |
| Packaging Details | BOX |
| Main Domestic Market | Madhya Pradesh |
Product Overview
Key Features
Crizotinib 250 Mg Capsules
| Dose/Strength : | 250 mg |
| Compostion : | Crizotinib 250 Mg Capsules |
| Packaging Type : | Strip |
| Packaging Size : | 6*10 Caps |
| Dosage Form : | Capsules |
| Country of Origin : | Made in India |
| Availability : | Available In Stock |
Company Details
CVS Biotech Pvt. Ltd. - we are the best Wholesaler, distributors, retailers of pharmaceutical tablets, vitamin, injections & tablets since 2013 in Indore, Madhya Pradesh.we supply both home and abroad, domestic and international. customers satisfaction is our top priority.
Business Type
Distributor, Supplier
Employee Count
50
Establishment
1988
Working Days
Monday To Sunday
GST NO
07AACCC7877Q1ZS
Payment Mode
Cash Against Delivery (CAD)
Related Products
More Products From This Seller
Seller Details
GST - 07AACCC7877Q1ZS
Indore, Madhya Pradesh
CEO
Mr Shri
Address
28, 4th Floor, Dawa Bazaar, R.N.T. Marg, Indore, Madhya Pradesh, 452001, India
Report incorrect details










![Crizotinib Intermediates - 5-Bromo-3-[(1R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy]Pyridin-2-Amine, CAS No: 877399-74-1, 99% Purity, White to Off-White Powder, 25kg Cardboard Drum](https://tiimg.tistatic.com/fp/1/005/131/crizotinib-intermediates-923.jpg)









